Answers are grounded in this paper and cite their sources.
hUC-MSCs may be an alternative source of stem cells and are worthy of study in long-term clinical trials.
No takes yet. Share an insight, caveat, or question.
Li et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: